Abstract
Since the late 1800s, bacterial products have been used as antitumor agents for the treatment of cancer patients. In spite of the fact that most patients treated with these products have been in advanced stages of the disease, the clinical results obtained have been generally encouraging and occasionally remarkable. Endotoxin has been shown to be one of the most potent antitumor components in these bacterial preparations. Therefore, endotoxin has been extensively studied in animal tumor models to determine the conditions under which it may be used most effectively against tumors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alexander, P., and Evans, R., 1971, Endotoxin and double-stranded RNA render macrophages cytotoxic, Nature New Biol. 232:76.
Arai, M., Nakahara, M., Hamano, K., and Okazaki, H., 1975, Isolation and characterization of antitumor lipopolysaccharide from Proteus mirabilis, Agnc. Biol. Chem. 39:1813.
Beebe, S. P., and Tracy, M., 1907, The treatment of experimental tumors with bacterial toxins,J. Am. Med. Assoc. 49:1493.
Behling, U. H., and Nowotny, A., 1977, Immune adjuvancy of lipopolysaccharide and a nontoxic hydrolytic product demonstrating oscillating effects with time, J. Immunol. 118:1905.
Bober, L. A., Kranepool, M. J., and Hollander, V. P., 1976, Inhibitory effect of endotoxin on the growth of plasma cell tumor, Cancer Res. 36:927.
Braun, V., 1973, Immunologic and antineoplastic effects of endotoxin: Role of membranes and mediation by cyclic adenosine-3′, 5′-monophosphate, J. Infect. Dis. 128 (Suppl.):118.
Butler, R. C., and Friedman, H., 1980a, Leukemia virus-induced immunosuppression: Reversal by subcellular factors, Ann. N. Y. Acad. Sci. 332:446.
Butler, R. C., and Friedman, H., 1980b, Restoration of leukemia cell immune responses by bacterial products, in: Current Chemotherapy and Infectious Disease (J. D. Nelson and C. Grassi, eds.), American Society for Microbiology, Washington, D. C.
Butler, R. C., and Nowotny, A., 1976, Colony stimulating factor (CSF)-containing serum has anti-tumor effects, IRCS Med. Sci. 4:206.
Butler, R. C., and Nowotny, A., 1979, Enhancement of nonspecific resistance to tumor by combinations of immunostimulatory bacterial products, Cancer Immunol. Immunother. 6:255.
Butler, R. C., Nowotny, A., and Friedman, H., 1977, Stimulation of an in vitro antibody response by endotoxin-induced soluble factors, J. Reticuloendothelial Soc. 22:28.
Butler, R. C., Abdelnoor, A. M., and Nowotny, A., 1978, Interrelationship between bone marrow colony-stimulating (CSF) and antitumor resistance (TUR) enhancing activities of post-endotoxin sera, Proc. Nat. Acad. Sci. USA 75:2893.
Butler, R. C., Nowotny, A., and Friedman, H., 1980a, Macrophage factors that enhance the antibody response, Ann. N.Y. Acad. Sci. 332:564.
Butler, R. C., Friedman, H., and Nowotny, A., 1980b, Restoration of depressed antibody responses of leukemic splenocytes treated with LPS-induced factors, Adv. Exp. Med. Biol. 121A:315.
Cameron, D. J., and Churchill, W. H., 1980, Cytotoxicity of human macrophages for tumor cells: Enhancement by bacterial lipopolysaccharides (LPS),J. Immunol. 124:408.
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B., 1975, An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Nat. Acad. Sci. USA 72:3666.
Chang, H., Thompson, J. J., and Nowotny, A., 1974, Release of colony stimulating factor (CSF) by non-endotoxic breakdown products of bacterial lipopolysaccharides, Immunol. Commun. 3:402.
Chedid, L., Parent, M., Parent, F., Gustafson, R. H., and Berger, F. M., 1972, Biological study of a nontoxic, water-soluble immunoadjuvant from mycobacterial cell walls, Proc. Nat. Acad. Sci. USA 69:855.
Coley, W. B., 1893, The treatment of malignant tumors by repeated inoculations of erysipelas, with a report of original cases, Am. J. Med. Sci. 105:487.
Copeland, M. M., 1967, Primary malignant tumors of bone: Evaluation of current diagnosis and treatment, Cancer 20:738.
Coutinho, A., 1976, Genetic control of B-cell responses. II. Identification of the spleen B-cell defect in C3H JHeJ mice, Scand. J. Immunol. 123:61.
Duran-Reynals, F., 1935, Reaction of spontaneous mouse carcinomas to blood-carried bacterial toxins, Proc. Soc. Exp. Biol. Med. 32:1517.
Evans, R., and Alexander, P., 1972, Mechanism of immunologically specific killing of tumor cells by macrophages, Nature (London) 236:168.
Felton, L. D., Kauffman, C., and Stahl, H. T., 1935, The precipitation of bacterial polysaccharides with calcium phosphate,J. Bacterwl. 29:149.
Fogg, L. C., 1936, Effect of certain bacterial products upon the growth of mouse tumor, Public Health Rep. 51:56.
Fowler, G. A., 1969a, Enhancement of Natural Resistance to Malignant Melanoma with Special Reference to the Beneficial Effects of Concurrent Infections and Bacterial Toxin Therapy, Monograph No. 9, New York Cancer Research Institute, New York.
Fowler, G. A., 1969b, Beneficiai Effects of Acute Bacterial Infections or Bacterial Toxin Therapy of Cancer of the Colon or Rectum, Monograph No. 10, New York Cancer Research Institute, New York.
Friedman, H., and Butler, R. C., 1979, Immunomodulatory effects of endotoxin-induced factors, in: Microbiology 1979 (D. Schlessinger, ed.), American Society for Microbiology, Washington, D.C.
Gardner, R. E., Bailey, G. H., and Hyde, R. R., 1939, Hemorrhagic activity of toxic carbohydrate complexes from bacteria on a transplantable rat tumor, Am. J. Hyg. 29:1.
Glaser, M., Djeu, J. Y., Kirchner, H., and Herberman, R. B., 1976, Augmentation of cell-mediated cytotoxicity against syngeneic Gross virus-induced lymphoma in rats by phytohemagglutinin and endotoxin,J. Immunol. 116:1542.
Gratia, A., and Linz, R., 1931, Le phénomène de Shwartzman dans la sarcome du cobaye, C. R. Soc. Bwl. 108:427.
Grohsman, J., and Nowotny, A., 1972, The immune recognition of TA3 tumors, its facilitation by endotoxin, and abrogation by ascites fluid,J. Immunol. 109:1090.
Hartwell, J. L., Shear, M. J., and Adams, J. R., 1943, Chemical treatment of tumors. VII. Nature of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigwsus) culture filtrate,J.Nat. Cancer Inst. 4:107.
Henderson, J. S., Migliore, R. D., and Berbrayer, D., 1976, Interference by cortisone with endotoxin’s adjuvator action on transplantation of a mouse tumour, J. Cancer Res. 33: 203.
Hoshi, A., Kanzawa, F., Kuretani, K., Homma, J. Y., and Abe, C., 1972, Anti-tumor activity of protein moiety of the Pseudomonas aeruginosa endotoxin, Gann 63:503.
Hoshi, A., Kanzawa, F., Kuretani, K., Homma, J. Y., Abe, C., 1973, Anti-tumor activity of constituents of Pseudomonas aeruginosa, Gann 64:423.
Männel, D. N., Farrar, J. J., and Mergenhagen, S. E., 1980, Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells, J. Immunol. 124: 1106.
Miller, T. R., and Nicholson, J. T., 1971, End results in reticulum cell sarcoma of bone treated by bacterial toxin therapy alone or combined with surgery and Jor radiotherapy (47 cases) or with concurrent infection (5 cases), Cancer 27:524.
Mita, A., 1972, Immunological evidences for proliferation and migration of lymphocytes induced by administration of potent antitumor phosphomucolipid in tumor-bearing mice, Rev. Eur. Etud. Clin. Biol. 17:860.
Mizuno, D., Yoshioka, O., Akamatu, M., and Kataoka, T., 1968, Antitumor effect of intracutaneous injection of bacterial lipopolysaccharide, Cancer Res. 28:1531.
Nakahara, M., Kitahara, N., Hamano, K., Arai, M., and Okazaki, H., 1975, Antitumor lipopolysaccharide from heptoseless mutant of Proteus mirabilis, Agnc. Biol. Chem. 39: 1821.
Nauts, H. C., Fowler, G. A., and Bogatko, F. H., 1953, A review of the influence of bacterial infection and of bacterial products (Coley’s toxins) on malignant tumors in man, Acta Med. Scand. 145(Suppl. 276): 103.
Ng, A. K., Butler, R. C., Chen, C.-L., and Nowotny, A., 1976, Relationship of structure to function in bacterial endotoxins. IX. Differences in the lipid moiety of endotoxic gly-colipids,J. Bacteriol. 126:511.
Nigam, V. N., 1975, Effect of core lipopolysaccharides from Salmonella minnesota R mutants on the survival times of mice bearing Ehrlich tumor, Cancer Res. 35:628.
Nowotny, A., and Butler, R. C., 1980, Studies on the endotoxin induced tumor resistance, Adv. Exp. Med. Biol. 121B:455.
Nowotny, A., Golub, S., and Key, B., 1971, Fate and effect of endotoxin derivatives in tumor-bearing mice, Proc. Soc. Exp. Biol. Med. 136:66.
Nowotny, A., Behling, U. H., and Chang, H. L., 1975, Relation of structure to function in bacterial endotoxins. VIII. Biological activities in a polysaccharide-rich fraction, J. Immunol. 115:199.
O’Malley, W. E., Achinstcin, B., and Shear, M. J., 1962, Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance,J. Nat. Cancer Inst. 29:1169.
Parr, I., Wheeler, E., and Alexander, P., 1973, Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA, Br. J. Cancer 27:370.
Pimm, M. V., and Baldwin, R. W., 1974, BCG immunotherapy of rat tumours in athymic nude mice, Nature (London) 254:77.
Prigal, S. J., 1968, A new application of mineral oil emulsions: The induction in mice of prolonged resistance to a variety of lethal challenges, Ann. Allergy 26:374.
Ribi, E., Meyer, T. J., Azuma, I., and Abar, B., 1972, Mycobacterial cell wall components in tumor suppression and regression, Nat. Cancer Inst. Monogr. 39:115.
Ribi, E., Granger, D. L., Milner, K. C., and Strain, S. M., 1975, Brief communication: Tumor regression caused by endotoxins and mycobacterial fractions, J. Nat. Cancer Inst. 55:1253.
Ribi, E., Takayama, K., Milner, K., Gray, G., Goren, M., Parker, R., McLaughlin, C., and Kelly, M., 1976, Regression of tumors by an endotoxin combined with trehalose mycolates of differing structure, Cancer Immunol. 1:265.
Ribi, E., Cantrell, J. L., Nowotny, A., Parker, R., Schwartzman, S. C., Von Eschen, K. B., and Wheat, R. W., 1979, Tumor regression caused by endotoxins combined with trehalose dimycolate, Toxicon 17:150.
Ruff, M. R., and Gifford, G. E., 1980, Purification and physico-chemical characterization of rabbit tumor necrosis factor,J. Immunol. 125:1671.
Shapiro, C. J., 1940, The effect of a toxic carbohydrate complex from S. ententidis on transplantable rat tumors in tissue cultures, Am. J. Hyg. 31:114.
Shear, M. J., and Andervont, H. B., 1936, Chemical treatment of tumors. III. Separation of hemorrhage-producing fraction of E. coll filtrate, Proc. Soc. Exp. Biol. Med. 34:323.
Shwartzman, G., 1936, Reactivity of malignant neoplasms to bacterial filtrates. II. Relation of mortality to hemorrhagic necrosis and regression elicited by certain bacterial filtrates, Arch. Pathol. 21:509.
Shwartzman, G., and Michailovsky, N., 1932, Phenomenon of local skin reactivity to bacterial filtrates in the treatment of mouse sarcoma 180, Proc. Soc. Exp. Biol. Med. 29: 737.
Stanley, E. R., Hansen, G., Woodcock, J., and Metcalf, D., 1975, Colony stimulating factor and the regulation of granulopoiesis and macrophage production, Fed. Proc. 34: 2272.
Strausser, H. R., and Bober, L. A., 1972, Inhibition of tumor growth and survival of aged mice inoculated with Moloney tumor transplants and treated with endotoxin, Cancer Res. 32:2156.
Tripodi, D., Hollenbeck, L., and Pollack, W., 1970, The effect of endotoxin on the implantation of a mouse sarcoma, Int. Arch. Allergy 37:575.
Wahl, S. M., 1974, Role of macrophages in inducing monocyte (MNL) chemotactic factor (CTF) production by guinea pig T and B lymphocytes, Fed. Proc. 33:744.
Wilton, J. L., Rosenstreich, D. L., and Oppenheim, J. J., 1975, Activation of guinea pig macrophages by bacterial lipopolysaccharide requires bone marrow derived lymphocytes,J. Immunol. 114:388.
Yang, C., and Nowotny, A., 1974, Effect of endotoxin on tumor resistance in mice, Infect. Immun. 9:95.
Yang-Ko, C., Grohsman, J., Rote, N., Jr., Nowotny, A., 1974, Non-specific resistance induced in allogeneic mice to the transplantable TA3-Ha tumor by endotoxin and its derivatives, 8th International Congress on Chemotherapy, Athens, pp. 193–197.
Yoshida, T., Sonozaki, H., and Cohen, S., 1973, The production of migration inhibition factor by B and T cells of the guinea pig, J. Exp. Med. 138:784
Zahl, P. A., Hutner, S. H., Spitz, S., Sugiura, K., and Cooper, F. S., 1942, Action of bacterial toxins on tumors. I. Relationship of tumor-hemorrhagic agent to endotoxin antigens of gram-negative bacteria, Am. J. Hyg. 36:224.
Zbar, B., Bernstein, I. D., and Rapp, H. J., 1972, Suppression of tumor growth at the site of infection with living Bacillus Calmette & Guerin,J. Natl. Cancer Inst. 46:831–839.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Butler, R.C. (1983). Enhancement of Nonspecific Resistance to Tumor by Endotoxin. In: Nowotny, A. (eds) Beneficial Effects of Endotoxins. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4364-6_25
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4364-6_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4366-0
Online ISBN: 978-1-4684-4364-6
eBook Packages: Springer Book Archive